Prothena to Report Third Quarter 2023 Financial Results on November 2
Prothena to Participate in Upcoming Healthcare Conferences
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Why Is Novo Nordisk Buying a Rare-Disease Candidate?
Why Biogen, Lilly, and Prothena Stocks Soared This Week
About · FAQs · StocksCafe © 2024 · Privacy · Terms